4
Changes in Ownership
SAB Biotherapeutics, Inc. Filed Acc 0001437749-23-006909
Options or other derivatives
- Chief Operating Officer acquired 275,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Bausch Christoph Lawrence Chief Operating Officer | 2023-03-14 | Grant or award · Employee Stock Option (right to buy) | +275,000 | 275,000 | D | ||
Loading xslF345X03/rdgdoc.xml…